Today: 8 June 2026
Browse Category

NYSE:DHR 21 October 2025 - 15 February 2026

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Danaher stock slides again after outlook: what DHR investors are watching next

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher shares fell 2.2% to $219.49 Thursday after its 2026 profit outlook matched analyst estimates. Fourth-quarter revenue rose 4.5% to $6.8 billion, with adjusted earnings at $2.23 per share. CEO Rainer Blair said China diagnostics revenue declined only slightly in Q4, improving from previous quarters. Investors remain cautious as sector peers warn of continued weakness in academic research spending.
29 January 2026
··
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher shares fell 4.8% to $224.54 after its 2026 profit outlook matched analyst expectations. The company beat fourth-quarter profit and revenue estimates, posting $6.8 billion in revenue and $2.23 per share in adjusted earnings. Trading volume more than doubled its 50-day average. Investors focused on the pace of recovery and upcoming results from rival Thermo Fisher.
29 January 2026
··
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher shares closed down 0.42% at $235.60 Wednesday, then edged up 0.16% after hours. CEO Rainer Blair will present at the J.P. Morgan Healthcare Conference Jan. 13, with Q4 earnings set for Jan. 28. Evercore ISI and TD Cowen raised price targets to $250 and $270, respectively. The stock traded between $233.26 and $238.00, with 2.7 million shares changing hands.
8 January 2026
··
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher closed at $231.47, up 0.28%, in a light, holiday-shortened session on Dec. 24, with after-hours trading slipping to $231.39. Trading volume was about 785,700 shares. A shareholder-rights law firm announced an investigation into Danaher’s officers and directors. No new corporate press releases were issued by the company.
25 December 2025
·
Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher shares traded near $227 Monday after Bank of America raised its price target to $265 and Wells Fargo lifted its target to $240. Both cited expectations for demand normalization in 2026. Bank of America kept a Buy rating, while Wells Fargo maintained Equal-Weight. Analysts highlighted Danaher as a key indicator for life sciences and diagnostics sector trends.
15 December 2025
·
Danaher Stock After Hours (Dec. 11, 2025): DHR Holds a Breakout Level—What to Watch Before the Market Opens Friday

Danaher Stock After Hours (Dec. 11, 2025): DHR Holds a Breakout Level—What to Watch Before the Market Opens Friday

Danaher closed Thursday at $232.37, up 0.85%, and edged to $232.99 in after-hours trading. The stock finished just above a key technical buy point near $232.34. Analyst targets remain in the mid-$250s after bullish commentary earlier in the week. No major company news or macro events are expected before Friday’s open.
12 December 2025
··
Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher shares traded at $227–$229 Thursday, rebounding over 30% from April’s low but still 11–12% below the 52-week high. The company faces board governance probes as Morgan Stanley upgrades the stock and new institutional buyers emerge. Danaher forecasts mid-single-digit revenue growth and margin expansion for 2026. Q3 2025 saw 3% core revenue growth and $2 billion in share buybacks.
4 December 2025
··
Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher traded near $225 per share on December 1, 2025, down about 1%–2% year-to-date and roughly 12% below its 52-week high. Market cap stands at $159–160 billion. Halper Sadeh LLC launched a shareholder-rights investigation into Danaher officers and directors on November 28, following similar probes by Rosen Law Firm in October. No lawsuits or regulatory actions have been filed.
1 December 2025
··
Danaher (DHR) Stock: Price, News and Analyst Forecast Before the December 1, 2025 Market Open

Danaher (DHR) Stock: Price, News and Analyst Forecast Before the December 1, 2025 Market Open

Danaher closed November 28 at $226.78, down 0.7%, with shares trading in a tight range and volume near 1.46 million. A shareholder-rights investigation was announced November 28 by Halper Sadeh LLC, targeting potential breaches by Danaher officers and directors. The company’s market cap stands near $160 billion, with a trailing P/E around 46–47x and a quarterly dividend of $0.32.
1 December 2025
·
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges After Q3 Earnings – Analysts See Further Upside

Danaher shares jumped 7% on Oct. 21 after Q3 adjusted EPS of $1.89 beat estimates and revenue reached $6.05 billion, up 4.5% year-over-year. The company kept its 2025 EPS guidance at $7.70–$7.80 and announced a $2 billion share buyback. Shares traded near $208, up 8% in a month but still down 20% from a year ago. Most analysts rate the stock a buy, with an average target of $245.
21 October 2025
···
1 2

Stock Market Today

  • Constellation Energy's Geothermal Expansion Tests Stock Valuation Amid Pullback
    June 8, 2026, 4:13 PM EDT. Constellation Energy (NasdaqGS:CEG) has completed a 25 MW geothermal expansion at The Geysers, supporting California's renewable goals and building on earlier projects. The unit Calpine, acquired for US$16.4 billion, drives this green energy push. Despite this, Constellation's stock price has dropped 30.4% year-to-date and 14.5% over 12 months, reflecting recent market volatility after a 177.4% rise in three years. Shares traded at US$254.83, about 31% below analysts' US$367.12 target, and 47.6% below estimated fair value per Simply Wall St. Investors should monitor how this capacity and renewables affect earnings, leverage, and the company's longer-term cash flow amid high debt and one-off expenses.

Latest articles

Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

8 June 2026
Tesla shares soared over 5% to $411.66 after a China sales report showed May retail sales up 22.5%, ending a two-month decline, and J.P. Morgan upgraded the stock, citing rising value from autonomy and software; the rally outpaced the Nasdaq as investors bet on Tesla’s China resilience and technology story despite a lofty price-to-earnings ratio of about 378.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

8 June 2026
Ondas shares slipped 0.5% to $10.38 as investors weighed a new $4.8M U.S. Navy-linked balloon contract and $110M in Q2 orders against high short interest (31.33% of float), rising operating losses, and fresh stock-supply concerns after a June 3 filing revealed more Omnisys-related shares could hit the market, raising dilution risks despite surging revenue and backlog.
Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

8 June 2026
Archer Aviation shares jumped 4.2% to $5.77 after last week’s 13.2% drop, as investors rotated back into growth and air-taxi stocks; the move follows Archer’s milestone as the first eVTOL developer to close Phase 3 of FAA certification, but heavy losses and high cash burn keep the stock highly sensitive to regulatory and financial risks.
Go toTop